MedTrace Logo

Superb Microvascular Imaging Ultrasonography of Plantar Fasciitis

NCT04979117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-12-28

No results posted yet for this study

Summary

A prospective study will be conducted to evaluate the diagnostic performance of SMI, gray scale US, color Doppler US and Power Doppler US.

Conditions

  • Diagnose Disease
  • Plantar Fasciitis

Interventions

DEVICE

Superb Microvascular Imaging (SMI) (Toshiba)

to determine whether there is a diagnostic value of SMI in Plantar Fasciitis and whether there is a superiority when compared Power Doppler and Color Doppler modalities.

Sponsors & Collaborators

  • Nigde Omer Halisdemir University

    lead OTHER

Principal Investigators

  • Ender Salbas, MD · Omer Halisdemir University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-28
Primary Completion
2022-12-27
Completion
2022-12-27

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04979117 on ClinicalTrials.gov